Abstract
The inorganic coordination chemistry of peroxovanadium compounds relevant to insulin mimesis is reviewed. The structure and kinetic reactivity of solutions of vanadate anion, vanadyl complexes and peroxovanadate complexes are briefly compared. Peroxovanadium compounds contain an oxo group, one or two peroxo ligands (O2 2−) and an ancillary ligand which is usually bidentate. These compounds approximate a trigonal bipyramidal structure which can be divided conceptually into a polar ‘oxo’ half and a relatively non-polar organic half. This presents a number of interesting design variations which are discussed with respect to the development of a rudimentary structure-activity correlation of insulin mimetic ability.
Similar content being viewed by others
Abbreviations
- phen:
-
1,10-phenanthroline
- 4,7-Me2phen:
-
4,7-dimethyl-1,10-phenanthroline
- 3,4,7,8-Me4phen:
-
3,4,7,8-tetramethyl-1,10-phenanthroline
- 5-CH3phen:
-
5-methyl-1,10-phenanthroline
- 5-NO2phen:
-
5-nitro-1,10-phenanthroline
- 5-NH2phen:
-
5-amino-1,10-phenanthroline
- bipy:
-
2,2′-bipyridine
- bipyH:
-
2,2′-bipyridinium
- 4,4′-Me2bipy:
-
4,4′-dimethyl-2,2′-bipyridine
- bipy-4,4′-(COO)2:
-
2,2′-bipyridine-4,4′-dicarboxylato
- pic:
-
pyridine-2-carboxylato
- 3-OHpic:
-
3-hydroxypyridine-2-carboxylato
- 3-acetpic:
-
3-acetatoxypyridine-2-carboxylato
- m,n-pdc:
-
pyridine-m,n-dicarboxylato
- ox:
-
oxalato
- pzc:
-
pyrazine-2-carboxylato
- 3-NH2pzc:
-
3-aminopyrazine-2-carboxylato
- 4OH-2,6pdc:
-
4-hydroxy-2,6-pyridinedicarboxylato
- IDA:
-
iminodiacetato
- cit:
-
citrato
- EDTA:
-
ethylenediaminetetraacetato
- HEDTA:
-
ethylene-diaminetetraacetic acid
- isoquin:
-
isoquinoline-2-carboxylato
- quin:
-
quinolato
- NTA:
-
nitrilotriacetato
- glyH:
-
glycine
- cystH:
-
cysteine
- nicH:
-
nicotinic acid
- Hheida:
-
N-(2-hydroxyethyl)iminodiacetato
References
Clark RJH: Vanadium. In: J.C. Bailar Jr, H.J. Emeléus, R. Nyholm (eds). A.F. Trotman-Dickenson (exec ed.). Comprehensive Inorganic Chemistry. Pergamon Press, Toronto, 1973, vol 3, pp 451–551.
Oltz EM, Bruening RC, Smith MJ, Kustin K, Nakanishi K: The tunichromes. A class of reducing blood pigments from sea squirts: Isolation, structures and vanadium chemistry. J Am Chem Soc 110: 6162–6172, 1988
Smith MJ, Kim D, Horenstein B, Nakanishi K, Kustin K: Unraveling the chemistry of tunichrome. Acc Chem Res 24: 117–124, 1991
Vilter H: Vanadium-an element involved in the biosynthesis of halogenated compounds and nitrogen fixation. Phytochemistry 23: 1387–1390, 1984
Weber R, de Boer E, Plat H, Krenn BE: Peroxidases from phaeophyceae: a vanadium(V)-dependent peroxidase fromAscophyllum nodosum. FEBS Lett 216: 1–3, 1987
Plat H, Krenn BE, Wever R: The bromoperoxidase from the lichenXanthoria parietina is a novel vanadium enzyme. Biochem J 248: 277–279, 1987
Krenn BE, Plat H, Wever R: The bromoperoxidase from the red algaCeranium rubrum also contains vanadium as a prosthetic group. Biochim Biophys Acta 912: 287–291, 1987
Hales BJ, Case EE, Morningstar JE, Dzeda MF, Mauterer LA: Isolation of a new vanadium containing nitrogenase fromAzotobacter vinelandii. Biochemistry 25: 7251–7255, 1986
Robson RL, Eady RR, Richardson TH, Miller RW, Hawkins M, Postgate JR: The alternative nitrogenase ofAzotobacter chroococcum is a vanadium enzyme. Nature 322: 388–390, 1986
Nechay BR, Nanninga LB, Nechay PSE, Post RL, Grantham JJ, Macara IG, Kubena LF, Phillips TD, Nielsen FH: Role of vanadium in biology. Fed Proc 45: 123–132, 1986
Rehder D: The bioinorganic chemistry of vanadium. Angew Chem Int Ed Engl 30: 148–167, 1990
Chasteen ND (ed.): Vanadium in biological systems. Kluwer Academic Publishers, Dordrecht, 1990
Tolman EL, Barris E, Burns M, Pansini A, Partridge R: Effects of vanadium on glucose metabolismin vitro. Life Sci 25: 1159–1164, 1979
Dubyak GR, Kleinzeller AD: The insulin-mimetic effects of vanadate in isolated rat adipocytes. Dissociation from the effects of vanadate as a (Na+/K+) ATPase inhibitor. J Biol Chem 255: 5306–5312, 1980
Shechter Y, Karlish SJD: Insulin-like stimulation of glucose oxidation in rat adipocytes by vanadyl (IV) ions. Nature 284: 556–558, 1980
Heyliger CE, Tahiliani AG, McNeill JH: Effect of vanadate on elevated blood glucose and depressed cardiac perforrnance of diabetic rats. Science 227: 1474–1477, 1985
Ramanadham S, Mongold JJ, Broonsey RW, Cros GH, McNell JH: Oral vanadyl sulfate in treatment of diabetes mellitus in rats. Am J Physiol 257: H904-H911, 1989
McNeill JH, Yuen VG, Hoveyda HR, Orvig C: Bis(maltolato)-oxovanadium(IV) is a potent insulin mimic. J Med Chem 35: 1489–1491, 1992
Shechter Y, Shisheva A, Lazar R, Libman J, Shanzer A: Hydrophobic carriers of vanadyl ions augment the insulinomimetic actions of vanadyl ions in rat adipocytes. Biochemistry 31: 2063–2068, 1992
Sakurai H: A new orally active insulin-mimetic vanadyl complex: bis(pyrrolidine-N-carbodithiotato)oxovanadium(IV). J Med Chem 37: 876–877, 1994
Kadota S, Fantus IG, Deragon G, Guyda HJ, Hersh B, Posner BI: Peroxide(s) of vanadium: a novel and potent insulin mimetic-agent which activates the insulin receptor kinase. Biochem Biophys Res Commun 147: 259–266, 1987
Posner BI, Burgess JW, Faure R, Bevan AP, Lachance D, Zhang-Sun G, Fantus IG, Ng JB, Hall DA, Soo Lum B, Shaver A: Peroxovanadium compounds: a new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J Biol Chem 269: 4596–4604, 1994
Crans DC: Aqueous chemistry of labile oxovanadates: relevance to biological studies. Comments Inorg Chem 16: 1–33, 1994
Crans DC: Enzyme interactions with labile oxovanadates and other polyoxometalates. Comments Inorg Chem 16: 35–76, 1994
Butler A, Parsons SM, Yamagata SK, De la Rosa RI: Reactivation of vanadate-inhibited enzymes with desferrioxamine B, a vanadium(V) chelator. Inorg Chim Acta 163: 1–3, 1989
Chasteen ND: Vanadyl(IV) EPR spin probes. Inorganic and biochemical aspects. Biol Magn Reson 3: 53–119, 1981
Butler A, Clague MJ, Meister GE: Vanadium peroxide complexes. Chem Rev 94: 625–638, 1994
Campbell NJ, Dengel AC, Griffith WP: Studies on transition metal peroxo complexes-X. The nature of peroxovanadates in aqueous solution. Polyhedron 8: 1378–1386, 1989
Sala-Pala J, Guerchais JE: Peroxo-complexes: triperoxovanadates(V) complexes. J Chem Soc (A) 1132–1136, 1971
Vuletic N, Djordjevic C: Oxodiperoxovanadate(V) complexes with bidentate ligands. J Chem Soc Dalton Trans 1137–1141, 1973
Bhattacharjee M, Chaudhuri MK, Islam NS, Paul PC: Synthesis, characterisation and physicochemical properties of peroxo-vanadium(V) complexes with glycine as the hetero-ligand. Inorg Chim Acta 169: 97–100, 1990
Vuletic N, Djordjevic C: Oxodiperoxovanadate(V) complexes with bidentate ligands. J Chem Soc Dalton Trans: 1137–114, 1973
Szentivanyi H, Stomberg R: The crystal structure of ammonium (2,2′-bipyridine) oxodiperoxovanadate (V) tetrahydrate, NH4[VO (O2)2(C10H8N2)]·4H2O, at −100°C. Acta Chem Scand A 37: 553–559, 1983
Schwendt P, Petrovic P, Uskert D: Oxo-peroxokomplexe des vanadiums(V). Z Anorg Allg Chem 466: 232–236, 1980
Begin D, Einstein FWB, Field J: An asymmetrically coordinated diperoxo compound. Crystal structure of K3[VO(O2)2(C2O4)]·H2O. Inorg Chem 14: 1785–1790, 1975
Schwendt P, Pisárcik M: Vibrational spectra of ammonium amine-oxodiperoxovanadate. Coll Czech Chem Commun 47: 1549–1555, 1982
Drew RE, Einstein FWB: The crystal structure of ammonium oxodiperoxoamminevanadate (V). Inorg Chem 11: 1079–1083, 1972
Hartkamp H: Darstellung von ammonium-[(pyridin-2,6-dicarboxylato)-oxo-peroxo-vanadat(V)]. Angew Chem 71: 553, 1959
Drew RE, Einstein FWB: Crystal structure at −100°C of ammonium oxoperoxo(pyridine-2,6-dicarboxylato)vanadate (V) hydrate, NH4− [VO(O2)(H2O)C5H3N(COO)2)·xH2O (x=1.3). Inorg Chem 12: 829–835, 1973
Mimoun H, Saussine L, Daire E, Postel M, Fischer J, Weiss R: Vanadium(V) peroxo complexes. New versatile biomimetic reagents for epoxidation of olefins and hydroxylation of alkanes and aromatic hydrocarbons. J Am Chem Soc 105: 3101–3110, 1983
Quilitzsch U, Wieghardt K: Kinetics of the diperoxovanadate(V)-monoperoxovanadate(V) conversion in perchloric acid media. Inorg Chem 18: 869–871, 1979
Shaver A, Ng JB, Hall DA, Soo Lum B, Posner BI: Insulin-mimetic peroxovanadium complexes: preparation and structure of potassium oxodiperoxo(pyridine-2-carboxylato)vanadate(V), K2[VO(O2)2− (C5H4NCOO)·2H2O, and potassium oxodiperoxo(3-hydroxypyridine-2-carboxylato)vanadate(V), K2[VO(O2)2(OHC5H3NCOO)]·3H2O, and their reactions with cysteine. Inorg Chem 32: 3109–3113, 1993
Mimoun H, Chaumette P, Mignard M, Saussine L: First d0 metal alkylperoxidic complexes. Synthesis, X-ray structure and hydroxylating properties of vanadium(V) dipicolinato alkylperoxides. Nouv J Chim 7: 467–475, 1983
Stomberg R: The crystal structures of potassium bis(oxalato)oxoperoxovanadate(V) hemihydrate, K3[VO(O2)(C2O4)2]·1/2H2O, and potassium bis(oxalato)dioxovanadate(V) trihydrate, K3[VO(O2)-(C2O4)2]·3H2O. Acta Chem Scand A40: 168–176, 1986
Szentivanyi H, Stomberg R: The crystal structure of (2,2′-bipyridine)-oxoperoxo (pyridine-2-carboxylato)vanadium(V) hydrate, [VO-(O2)(C5H4NCOO)(C10H8N2)]·H2O at −100°C. Acta Chem Scand A37: 709–714, 1983
Basumatary JK, Chaudhuri MK, Dutta Purkayastha RN, Hiese Z: First synthesis and structural assessment of alkali-metal carbonatodioxoperoxouranate(VI) monohydrates, A2[UO2(O2) CO3)]·H2O, and carbonatooxodiperoxovanadate(V) trihydrates, A3[VO(O2)2(CO3)]-·3H2O. J Chem Soc Dalton Trans: 709–711, 1986
Stomberg R: The crystal structure of potassium carbonatooxodiperoxovanadate(V), K3[VO(O2)2(CO3)]. Acta Chem Scand A39: 725–731, 1985
Shaver A, Hall DA, Ng JB, Lebuis AM, Hynes RC, Posner BI: Bisperoxovanadium compounds: Synthesis and reactivity of some insulin-mimetic complexes. Inorg Chim Acta 229: 253–260, 1995
Shaver A, Ng JB, Hynes RC, Posner BI: Postassium (5-nitro-1, 10-phenanthroline-N1,N10) oxodiperoxovanadate(V) dihydrate: an insulin mimetic peroxovanadate. Acta Cryst Sect C C50: 1044–1046, 1994
Djordjevic C, Craig SA, Sinn E: A polymeric peroxo heteroligand vandadate(V). Synthesis, spectra, and structure of M1[VO(O2)(C4H5− O4N). Inorg Chem 24: 1281–1283, 1985
Djordjevic C, Lee M, Sinn E: Oxoperoxo(citrato)- and dioxo(citrato)vanadates(V): synthesis, spectra and structure of a hydroxyl oxygen bridged dimer K2[VO(O2)(C6H6O7).]2·2H2O Inorg Chem 28: 719–723, 1989
Chaudhuri MK, Ghosh SK: Synthesis of alkali oxydiperoxyfluorovanadates(V). Polyhedron 1: 553–555, 1982
Stomberg R: The crystal structure of potassium fluorooxodiperoxovanadate(V), K2[VFO(O2)2]. Acta Chem Scand A38: 223–228, 1984
Stomberg R: The crystal structure of ammonium difluorooxodiperoxovanadate(V), (NH4)3[VF2O(O2)2]. Acta Chem Scand A38: 541–545, 1984
Djordjevic C, Wampler GL: Antitumour activity and toxicity of peroxo heteroligand vanadates(V) in relation to biochemistry of vanadium. J Inorg Biochem 25: 51–55, 1985
Wieghardt K: Preparation and characterization of dipicolinatovanadium(V) complexes. Kinetics and mechanism of their reaction with hydrogen peroxide in acidic media. Inorg Chem 17: 57–64, 1978
Schwendt P, Sivak M, Lapshin AE, Smolin She, Shepelev YF, Gyepesova D: Ethylenediaminetetraacetato-monoperoxo complexes of vanadium(V). Trans Metal Chem 19: 34–36, 1994
Vilter H, Rehder D: 51V NMR investigation ofa vanadium(V)-dependant peroxidase fromAscophyllum nodosum (L) lejool. Inorg Chim Acta 136: L7-L10, 1987
Campbell NJ, Capparelli MV, Griffith WP, Skapski AC: On the existence of triperoxo vanadium complexes. X-Ray crystal structures of K3[VO(O2)2(C2O4)]·H2O2 and of (NH4)[VO(O2)2(bipy)]·4H2O. Inorg Chim Acta 77: L215-L216, 1983
Szentivanyi H, Stomberg R: The crystal structure of 2,2′-bipyridinium (l+)μ-hydrogen-bis[(2,2′-bipyridine)oxodiperoxovanadate](1-)-x x-hydrogen peroxide-(6-x)-water, (Hbipy)[H{VO(O2)2 bipy}2]-·xH2O2-(6-x)H2O, x≈0.5, at −100°C. Acta Chem Scand A38: 101–107, 1984
Stomberg R, Szentivanyi H: The crystal structure of 2,2′-bipyridinium(l+) (2,2′-bipyridine)oxodiperoxovanadate(l-)-(3+x)-hydrogen peroxide-(2-x)-water, (C10H9N2)[VO(O2)2 (C10H9N2)]·(3+x)H2O2-(2-x)H2O, x≈0.4, at −100°C. Acta Chem Scand A38: 121–128, 1984
Bhattacharjee M, Chaudhuri MK, Paul PC: Synthesis and physicochemical studies of newer mono and diperoxo heteroligand complexss of vanadium. Can J Chem 70: 2245–2248, 1992
Chaudhuri M. K., Paul PC: Complex peroxovanadates(V) containing the chelated cysteinate as the co-ligand: synthesis and spectroscopic studies. Ind J Chem 31A: 466–468, 1992
Chaudhuri MK, Ghosh SK: Alkali-metal and ammonium triperoxyfluorovanadates(V), A2[V(O2)3F]. Inorg Chem 21: 4020–4022, 1982
Chaudhuri MK, Ghosh SK, Islam NS: First synthesis and structural assessment of alkali-metal triperoxovanadates(V), A[V(O2)3]. Inorg Chem 24: 2706–2707, 1985
Wu D, Lei X, Cao R, Hong M: Synthesis and structure of the peroxovanadium(V) complex containing the nitriloacetate Na2[VO-(O2)N(CH2COO)3]·5H2O. Jiegou Huaxue 11: 65–67, 1992
Wei YG, Zhang SW, Huang GQ, Shao MC: Synthesis, spectrum and lingle crystal structure of a peroxovanadium complex of nitrilotriacetate ligand without water of crystallization, K2[VO(O2)NTA]. Polyhedron 13: 1587–1591, 1994
Kuchta L, Sivak M, Pavelcik F: Synthesis, characterization and crystal structure of barium (nitrilotriacetato)oxoperoxovanadate(V) trihydrate. J Chem Res S 393, 1993
Chaudhuri MK, Ghosh SK: The [VO(O2)2Cl]2-[V(O2)3Cl]2− pair in peroxovanadium(V) chemistry: Synthesis of the first chloroperoxyvanadate(V) compounds and evidence for diperoxyvanadate(V)-triperoxyvanadate(V) interconversion. Inorg Chem 23: 534–537, 1984
Bhattacharjee M, Chaudhuri MK, Islam NS, Paul PC: Synthesis characterization and physicochemical properties of peroxo-vanadium(V) complexes with glycine as the heteroligand. Inorg Chim Acta 169: 97–100, 1990
Bhattacharjee MN, Chaudhuri MK, Islam NS: Reactivity of coordinated peroxide at a highly peroxygenated vanadium(V) center in an aqueous medium. Inorg Chem 28: 2420–2423, 1989
Jaswai JS, Tracey AS: Formation and decomposition of peroxovanadium complexes in a queous solution. Inorg Chem 30: 3718–3772, 1991
Stomberg R, Olson Sv, Svensson IB: The crystal structure of ammonium-μ-oxobis (oxodiperoxovanadate) (4-), (NH4)4[O{VO(O2)2}2]. A refinement. Acta Chem Scand. A38: 653–656, 1984
Campbell NJ, Flanagan J, Griffith WP, Skapski, AC: X-ray structure of the peroxovanadate [HV2O11]3− ion in the ammonium peroxovanadate salt (NH4)3[HO{VO(O2)2}2]·H2O. Trans Met Chem 10: 353–354, 1985
Djordjevic C, Puryear BC, Vuletic N, Abelt CJ, Sheffield SJ: Preparation, spectroscopic properties, and characterization of novel peroxo complexes of vanadium(V) and molybdenum(VI) with nicotinic acid and nicotinic acid N-oxide. Inorg Chem 27: 2926–2932, 1988
Colpas GJ, Hamstra BJ, Kampf JW, Pecoraro VL: A functional model for vanadium haloperoxidase. J Am Chem Soc 116: 3627–3628, 1994
Szentivanyi H, Stomberg R: The crystal structure of (2,2′-bipyridine) oxoperoxo(pyridine-2-carboxylato)vanadium(V) hydrate. Acta Chem Scand A37: 709–714, 1983
Lever ABP, Gray HB: Electronic spectra of metal-dioxygen complexes. Acc Chem Res 11: 348–355, 1978
Rehder D, Wieghardt K: The51V NMR spectra of some oxo-, peroxo-, nitrosyl- and hydroxylamidovanadium complexes. Z Naturforsch 36B: 1251–1254, 1981
Rehder D, Weidemann C, Duch A, Priebsch W:51V shielding si vanadium(V) complexes: A reference fcals for vanadium binding sites in biomolecules. Inorg Chem 27: 586–587, 1988
Yale J-F, Lachance D, Bevan AP, Vigeant C, Shaver A, Posner, Bl: Hypoglycemic effects of peroxovanadium compounds in Sprague-Dawley and diabetic BB rats. Diabetes in press
Barford D, Flint AJ, Tonks NK: Crystal structure of human protein tyrosine phosphatase 1B. Science 263: 1397–1404, 1994
Gresser MJ, Tracey AS: Vanadates as phosphate analogs in biochemistry. In: N.D. Chasteen (ed.). Vanadium in Biological systems. Kluwer Academic Publishers, Dordrecht, 1990, pp 63–79
Ballistreri FP, Tomaselli GA, Toscano RM, Conte V, DiFuria F: Application of the thiantherene 5-oxide mechanistic probe to peroxometal complexes. J Am Chem Soc 113: 6209–6212, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shaver, A., Ng, J.B., Hall, D.A. et al. The chemistry of peroxovanadium compounds relevant to insulin mimesis. Mol Cell Biochem 153, 5–15 (1995). https://doi.org/10.1007/BF01075913
Issue Date:
DOI: https://doi.org/10.1007/BF01075913